Communications
OYE1 proteins was observed at a concentration of 850 mm ammo-
nium sulfate. The purification was followed by a filtration and
desalting step with Vivaspin ultrafiltration spin columns (Vivaspin
10 kDa, Sartorius, Gçttingen, Germany) and concentrated in
Tris·HCl reaction buffer (50 mm, pH 7.5). The purified enzyme was
stored at À208C until further use.
late the engineering of enzymes with modified and improved
enzyme properties.
Experimental Section
General remarks: Restriction endonucleases, Pfu DNA polymerase
and T4 DNA ligase were purchased from Fermentas (Thermo Scien-
tific). Primers were obtained from Metabion (Matrinsried, Germany).
Unless otherwise specified, chemicals were obtained from Fluka,
Sigma–Aldrich, Carl Roth, SAFC (Hamburg, Germany) or BASF SE.
GC-FID analyses were carried out with a Shimadzu GC-2010 instru-
ment equipped with an AOC-20i auto injector and a HP-5 capillary
column (Agilent technologies, 30 m0.25 mm0.25 mm) with H2
as carrier gas (1.38 mLminÀ1). Standard molecular biology tech-
niques such as overlapping extension PCR, restriction digestion, li-
gation, heat shock transformation as well as protein concentration
determination were used as previously described.[11,12]
Biotransformation reactions: All biotransformation reactions were
carried out with purified enzyme (protein purity >95%). Biotrans-
formations were performed with NADH (5 mm), purified enzyme
(100 mgmLÀ1), ADH equine (0.2 U, Sigma–Aldrich) and Tris·HCl
(1 mL, 50 mm, pH 7.5). The biotransformation was started by
adding substrate [2 mm (cinnamyl alcohol, geraniol, (S)-(À)-perillyl
alcohol]. After incubation (24 h, 308C, 180 rpm), the reaction was
stopped by extraction with methyl-tert-butylether (MTBE; 2
500 mL). Activity tests towards cinnamaldehyde were performed
with cinnamaldehyde (2 mm), NADH (2.5 mm) and purified protein
(50 mgmLÀ1) in Tris·HCl (1 mL, 50 mm, pH 7.5) for 2.5 h at 308C and
180 rpm, followed by extraction with MTBE (2500 mL). Assays
with varying cofactor concentrations contained cinnamaldehyde
(2 mm), NADH/NAD+ cofactor (1:0, 4:1, 1:1, 5 mm) and purified
enzyme (100 mgmLÀ1) in Tris·HCl (1 mL, 50 mm, pH 7.5) for 24 h at
308C and 180 rpm, and were stopped by extraction with MTBE (2
500 mL).
Protein expression and purification: The two wild-type enzymes
NCR and MR, as well as the four loop-grafted variants, were cloned
in pET-28a(++) and expressed in TB medium with kanamycin
(50 mgmLÀ1) in Escherichia coli BL21(DE3). Enzyme expression was
induced at an OD600 of 0.5–0.6 with IPTG (0.2 mm) at 308C for 20 h.
After harvesting by centrifugation (9000g, 30 min, 48C), the cells
were disrupted with a French press (EmulsiFlex-C5, Avestin, Mann-
heim, Germany) and purified by immobilised metal affinity chroma-
tography with an ¾KTA system. OYE1 wild-type enzyme was
cloned into a pDHE vector and also expressed in E. coli BL21(DE3)
under the following conditions: 378C, 180 rpm in TB medium
(400 mL) containing ampicillin (100 mg). When the cultures
reached an OD600 of 1.3–1.6, they were supplemented with l-
rhamnnose (0.2%) for protein expression. After 14 h of incubation
at 308C (160 rpm), cells were harvested by centrifugation (8000g,
15 min, 48C) and resuspended in potassium phosphate buffer
(50 mm, pH 7.4) containing phenylmethanesulfonyl fluoride (PMSF,
0.1 mm). Cell pellets were disrupted in two or three cycles with
a French press (EmulsiFlex-C5, Avestin, Mannheim, Germany) at
48C. The resulting crude extracts were centrifuged (37000g,
30 min, 48C), and the supernatants with the soluble proteins were
recovered. Protein purification was performed in three steps:
1) ammonium sulfate precipitation, 2) fast protein liquid chroma-
tography (FPLC), and 3) hydrophobic interaction chromatography
(HIC). Protein precipitation of the lysate was performed with am-
monium sulfate (24% final concentration). Subsequently, the lysate
was centrifuged (7000g) for 15 min at 48C, and the protein pellet
was discarded. The ammonium sulfate concentration was then in-
creased to an end concentration of 45%, followed by centrifuga-
tion (7000g, 15 min, 48C), and the supernatant was discarded. Af-
terwards the proteins were resuspended in potassium phosphate
buffer (50 mm, pH 7.8). FPLC was carried with Q-Sepharose FF col-
umns (GE Healthcare) packed to a volume of 275 mL and a maxi-
mum flow of 20 mLminÀ1. The column was washed (10 mLminÀ1
working flow) by a step gradient protocol with potassium phos-
phate buffer (50 mm, pH 7.8) containing ammonium sulfate (1.4m).
The elution of the OYE1 proteins was observed at a concentration
of 400 mm ammonium sulfate. In addition to the characteristic
total protein detection at 280 nm, OYE1 was identified by its ab-
sorbance at 455 nm. HIC was performed with a phenyl Sepharose
HP column (GE Healthcare, Freiburg, Germany). The column was
packed with a maximum flow of 18 mLminÀ1 to a volume of
240 mL. The elution buffer contained potassium phosphate
(50 mm, pH 7.2) and ammonium sulfate (1.4m). The elution of the
GC-FID analytics: Levels of conversion were determined from the
percent area of the product. Samples were directly analysed from
the MTBE phase without derivatisation by using a HP-5 capillary
column (30 m0.25 mm0.25 mm, Agilent) and one of two differ-
ent temperature programs. The program for cyclic substrates (cin-
namyl alcohol, (S)-(À)-perillyl alcohol and cinnamaldehyde) was
708C, 158CminÀ1 to 2008C, 308CminÀ1 to 3208C, hold 1 min. The
program for the aliphatic substrate (geraniol) was 3 min at 608C,
108CminÀ1 to 1508C, 508CminÀ1 to 3008C, hold 1 min. The injector
temperature was 2508C. Compounds were detected by flame ioni-
sation detection(FID) at 3258C and identified by coelution with
standards.
Acknowledgements
We gratefully acknowledge financial support from the Landes-
graduiertenfçrderung (LSFG) Baden–Württemberg and the Euro-
pean Community’s Seven Framework Program (FP7/2007–2013)
for the Innovative Medicine Initiative under Grant Agreement
no. 115360 (Chemical manufacturing methods for the 21st centu-
ry pharmaceutical industries, Chem21).
Keywords: allylic alcohols · biocatalysis · cascade reactions ·
loop grafting · oxidoreductases · reduction
[2] N. Oberleitner, C. Peters, F. Rudroff, U. T. Bornscheuer, M. D. Mihovilovic,
[3] N. Oberleitner, C. Peters, J. Muschiol, M. Kadow, S. Saß, T. Bayer, P.
Schaaf, N. Iqbal, F. Rudroff, M. D. Mihovilovic, U. T. Bornscheuer, Chem-
[4] C. Peters, R. Koelzsch, M. Kadow, L. Skalden, F. Rudroff, M. D. Mihovilov-
[6] S. Gargiulo, D. J. Opperman, U. Hanefeld, I. W. C. E. Arends, F. Hollmann,
ChemBioChem 2016, 17, 561 – 565
564
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim